Accessibility settings

This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (1209) Non-randomized Protocols and Methods (ehealth) (1089) Methods and Feasibility Studies (745) Statistical Methods (46) Immunology, Allergy, Rheumatology (191)

Published on in Vol 15 (2026)

This is a member publication of University of Cambridge (Jisc)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/81415, first published .
Doctor reviewing medical data with digital health icons

Evaluation of the Long-Term Safety of Avacopan in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in the Real World (AvacoStar): Protocol for a Noninterventional Prospective Cohort Study

Evaluation of the Long-Term Safety of Avacopan in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in the Real World (AvacoStar): Protocol for a Noninterventional Prospective Cohort Study

Authors of this article:

David R W Jayne1 Author Orcid Image ;   Raashid Luqmani2 Author Orcid Image ;   Benjamin Terrier3 Author Orcid Image ;   Achim Obergfell4 Author Orcid Image ;   Charlotte Pollet4 Author Orcid Image ;   Marie Boff5 Author Orcid Image ;   Monica Balcells-Oliver4 Author Orcid Image ;   Bernhard Hellmich6 Author Orcid Image
Article Authors Cited by (1) Tweetations (5) Metrics

Journals

  1. van Schaik M, van Kooten C, Arnaud L, Bruchfeld A, Caravaca-Fontán F, Fernandez Juarez G, Floege J, Malvar A, Mirioglu S, Moran S, Parodis I, Quintana L, Rovin B, Steiger S, Stevens K, Kronbichler A, Teng Y, Frangou E. Disease modification in lupus nephritis: towards a pathophysiology-based treatment paradigm. Nature Reviews Nephrology 2026 View